Hydroxyurea, 5-Fluorouracil Infusion, and Cisplatin Adjunct to Radiation Therapy in Cervical Carcinoma: A Phase I–II Trial of the Gynecologic Oncology Group

This publication has 19 references indexed in Scilit:

• Effect of cisplatin on the clinically relevant radiosensitivity of human cervical carcinoma cell lines
  International Journal of Radiation Oncology*Biology*Physics, 1996
• Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial.
  Journal of Clinical Oncology, 1993
• Concurrent chemoradiation in advanced cervical cancer
  Gynecologic Oncology, 1990
• Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study.
  Journal of Clinical Oncology, 1989
• The effect of cisplatin on the repair of radiation damage in RIF 1 mouse tumours in vivo
  Radiotherapy and Oncology, 1989
• Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.
  Journal of Clinical Oncology, 1985
• Biological basis for the interaction of chemotherapeutic agents and radiation therapy
  Cancer, 1985
• Concurrent radiation, mitomycin C and 5-fluorouracil in poor prognosis carcinoma of cervix: Preliminary results of a phase I-II study
  International Journal of Radiation Oncology*Biology*Physics, 1984
• Hydroxyurea or placebo combined with radiation to treat stages iiib and iv cervical cancer confined to the pelvis
  International Journal of Radiation Oncology*Biology*Physics, 1979
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958